In women with type 2 diabetes, GLP-1 receptor agonists may protect against new-onset uterine fibroids compared to both metformin and insulin, Hsieh said
Maintenance dose: The dose you stay on long-term once you've reached your target or a stable response
Bayesian Network Meta-Analysis Comparisons of the Glucose-Lowering and Weight-Loss Effects Our NMA involved 48 monotherapy trials, whose comparators included acarbose (300 mg/day), DPP-4is, metformin (1,500 mg/day), pioglitazone (45 mg/day), and placebo
O., Felty, Q., Parkash, J., Poppiti, R
When patients ignored this advice and rushed to dose increases to get quicker results, stomach complaints often piled up in the first two months, leading to lower adherence
Understanding that your symptoms are rooted in real, physiological processeslike the breakdown of the carnitine shuttle and the failure of mitochondrial energy productioncan be incredibly validating